Huakang
8622.HKHuakang Biomedical Holdings Company Limited Price (8622.HK)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
415,962,411
(2.7984)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Huakang Biomedical Holdings Company LimitedCurrency: HKD
| YEAR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
19,456,000.00
+0% |
25,410,000.00
+31% |
26,541,000.00
+4% |
28,677,000.00
+8% |
25,471,000.00
-11% |
21,967,000.00
-14% |
26,127,000.00
+19% |
25,330,000.00
-3% |
24,629,000.00
-3% |
||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 5,088,000.00 | 7,788,000.00 | 8,007,000.00 | 7,097,000.00 | 7,580,000.00 | 7,249,000.00 | 9,671,000.00 | 8,416,000.00 | 8,536,000.00 | ||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
14,368,000.00
+0% |
17,622,000.00
+23% |
18,534,000.00
+5% |
21,580,000.00
+16% |
17,891,000.00
-17% |
14,718,000.00
-18% |
16,456,000.00
+12% |
16,914,000.00
+3% |
16,093,000.00
-5% |
||||||||||
| Gross Profit Ratio | (0.74%) | (0.69%) | (0.70%) | (0.75%) | (0.70%) | (0.67%) | (0.63%) | (0.67%) | (0.65%) | ||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 1,644,000.00 | 1,210,000.00 | 1,374,000.00 | 1,474,000.00 | 1,762,000.00 | 2,253,000.00 | 2,437,000.00 | 2,483,000.00 | 2,553,000.00 | ||||||||||
| General and Administrative | 436,000.00 | 896,000.00 | 13,312,000.00 | 13,580,000.00 | 9,679,000.00 | 10,191,000.00 | 9,353,000.00 | 9,803,000.00 | 9,874,000.00 | ||||||||||
| Selling, General & Admin... | 3,170,000.00 | 3,806,000.00 | 16,172,000.00 | 17,648,000.00 | 16,456,000.00 | 17,315,000.00 | 17,699,000.00 | 18,754,000.00 | 18,491,000.00 | ||||||||||
| Selling & Marketing Exp... | 2,734,000.00 | 2,910,000.00 | 2,860,000.00 | 4,068,000.00 | 6,777,000.00 | 7,124,000.00 | 8,346,000.00 | 8,951,000.00 | 8,617,000.00 | ||||||||||
| Depreciation and Amortiz... | 511,000.00 | 908,000.00 | 1,422,000.00 | 1,691,000.00 | 2,762,000.00 | 3,194,000.00 | 2,949,000.00 | 3,140,000.00 | 3,179,000.00 | ||||||||||
| Other Expenses | -72,000.00 | 3,000.00 | 2,000.00 | -150,000.00 | -94,000.00 | 2,999,000.00 | 100,000.00 | 37,000.00 | -4,951,000.00 | ||||||||||
| Total Operating Expenses | 5,099,000.00 | 6,418,000.00 | 19,155,000.00 | 18,972,000.00 | 18,124,000.00 | 22,567,000.00 | 20,236,000.00 | 21,274,000.00 | 16,093,000.00 | ||||||||||
| Cost and Exponses | 10,187,000.00 | 14,206,000.00 | 27,162,000.00 | 26,069,000.00 | 25,704,000.00 | 29,816,000.00 | 29,907,000.00 | 29,690,000.00 | 32,020,000.00 | ||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
10,481,000.00
+0% |
11,361,000.00
+8% |
-193,000.00
-102% |
2,603,000.00
-1,449% |
470,000.00
-82% |
-8,742,000.00
-1,960% |
-3,801,000.00
-57% |
-2,952,000.00
-22% |
-6,483,000.00
+120% |
||||||||||
| Operating Income Ratio | (0.54%) | (0.45%) | (-0.01%) | (0.09%) | (0.02%) | (-0.40%) | (-0.15%) | (-0.12%) | (-0.26%) | ||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 1,290,000.00 | 159,000.00 | 143,000.00 | 84,000.00 | 174,000.00 | 185,000.00 | 179,000.00 | 402,000.00 | 404,000.00 | ||||||||||
| Interest Expenses | 1,278,000.00 | 123,000.00 | 54,000.00 | 1,361,000.00 | 72,000.00 | 74,000.00 | 102,000.00 | 55,000.00 | 53,000.00 | ||||||||||
| Total Other Income/Exp... | -66,000.00 | -1,260,000.00 | -54,000.00 | -1,390,000.00 | 641,000.00 | -2,745,000.00 | 675,000.00 | 2,083,000.00 | 701,000.00 | ||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 10,992,000.00 | 12,269,000.00 | 1,229,000.00 | 4,294,000.00 | 3,492,000.00 | -8,104,000.00 | -852,000.00 | 188,000.00 | -2,550,000.00 | ||||||||||
| EBITDA ratio | (0.56%) | (0.48%) | (0.05%) | (0.15%) | (0.13%) | (-0.25%) | (-0.03%) | (0.01%) | (-0.10%) | ||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 9,203,000.00 | 9,944,000.00 | -247,000.00 | 1,242,000.00 | 658,000.00 | -11,372,000.00 | -3,903,000.00 | -3,007,000.00 | -5,782,000.00 | ||||||||||
| Income Before Tax Ratio | (0.47%) | (0.39%) | (-0.01%) | (0.04%) | (0.03%) | (-0.52%) | (-0.15%) | (-0.12%) | (-0.23%) | ||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 1,269,000.00 | 1,518,000.00 | 1,705,000.00 | 1,701,000.00 | 942,000.00 | 255,000.00 | 317,000.00 | 68,000.00 | 0.00 | ||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 7,934,000.00
+0% |
8,426,000.00
+6% |
-1,952,000.00
-123% |
-459,000.00
-76% |
-284,000.00
-38% |
-11,627,000.00
+3,994% |
-4,220,000.00
-64% |
-3,075,000.00
-27% |
-5,782,000.00
+88% |
||||||||||
| Net Income Ratio | (0.41%) | (0.33%) | (-0.07%) | (-0.02%) | (-0.01%) | (-0.53%) | (-0.16%) | (-0.12%) | (-0.23%) | ||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | -0.03 | -0.01 | -0.01 | -0.01 | ||||||||||
| Diluted EPS | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | -0.03 | -0.01 | -0.01 | -0.01 | ||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 400,000,000.00 | 400,000,000.00 | 400,000,000.00 | 305,205,000.00 | 400,000,000.00 | 400,000,000.00 | 400,000,000.00 | 404,638,970.00 | 415,962,411.00 | ||||||||||
| Diluted Share Outstanding | 400,000,000.00 | 400,000,000.00 | 400,000,000.00 | 305,205,000.00 | 400,000,000.00 | 400,000,000.00 | 400,000,000.00 | 404,638,970.00 | 415,962,411.00 | ||||||||||